Appointment booking for Dr. Suhasini Gudipati, MD is currently not available.Dr. Suhasini Gudipati, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Suhasini Gudipati, MD (he/him) is a Infectious Disease Doctor in Saginaw, MI with over 18 years of experience. What is your opinion of Dr. Suhasini Gudipati, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Suhasini Gudipati, MD has received over $643 which includes payments from the following companies:
$148.06 from Janssen Pharmaceuticals, Inc
$97.50 from Smith & Nephew, Inc.
$78.19 from Organogenesis Inc.
$64.25 from Novo Nordisk Inc
$41.15 from E.R. Squibb & Sons, L.L.C.
$36.68 from Actavis Pharma Inc
$29.37 from The Medicines Company
$20.55 from KCI USA, Inc
$19.63 from Hollister Incorporated
$16.61 from Merck Sharp & Dohme Corporation
$15.68 from Alexion Pharmaceuticals, Inc.
$12.16 from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$12.16 from Sunovion Pharmaceuticals Inc.
$11.52 from Kastle Therapeutics LLC
$10.83 from Pfizer Inc.
$10.55 from Allergan Inc.
$10.53 from Tactile Systems Technology Inc
$8.24 from Aroa Biosurgery Incorporated
Payments received by Dr. Suhasini Gudipati, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!